INTERLEUKIN GENETICS INC 4
4 · INTERLEUKIN GENETICS INC · Filed May 12, 2017
Insider Transaction Report
Form 4
Toutain Stephan
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-04-19+182,547→ 182,547 totalExercise: $0.10Exp: 2027-04-19→ Common Stock (182,547 underlying)
Footnotes (2)
- [F1]The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on April 19, 2017, which was the grant date of the option.
- [F2]The option vests as to 25% of the shares on April 19, 2018, and 1/36th of the shares on the first day of each month beginning on May 1, 2018.